Literature DB >> 21697856

Novel and recurrent EMD mutations in patients with Emery-Dreifuss muscular dystrophy, identify exon 2 as a mutation hot spot.

Charlotte A Brown1, Juergen Scharner, Kevin Felice, Matthew N Meriggioli, Mark Tarnopolsky, Matthew Bower, Peter S Zammit, Jerry R Mendell, Juliet A Ellis.   

Abstract

Emery-Dreifuss muscular dystrophy (EDMD) is a neuromuscular disorder exhibiting a cardiomyopathy with cardiac conduction defects. X-linked EDMD arises from mutations in the EMD gene, which encodes for a nuclear membrane protein termed emerin. In this study, we describe novel and recurrent EMD mutations identified in 18 probands and three carriers from a cohort of 255 North American patients referred for EDMD genetic mutation analysis. Eight of these mutations are novel including six frameshift mutations (p.D9GfsX24, p.F39SfsX17, p.R45KfsX16, p.F190YfsX19, p.R203PfsX34 and p.R204PfsX7) and two non-sense mutations (p.S143X, p.W200X). Our data augment the number of EMD mutations by 13.8%, equating to an increase of 5.2% in the total known EMD mutations and to an increase of 6.0% in the number of different mutations. Analysis of the exon distribution of mutations within the EMD gene, suggests a nonrandom distribution, with exon 2 as a hot spot. This phenomenon may be due to its high GC content, which at 60% is the most GC-rich exon in the EMD gene.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21697856     DOI: 10.1038/jhg.2011.65

Source DB:  PubMed          Journal:  J Hum Genet        ISSN: 1434-5161            Impact factor:   3.172


  9 in total

1.  Whole Exome Sequencing Identifies Truncating Variants in Nuclear Envelope Genes in Patients With Cardiovascular Disease.

Authors:  Gloria T Haskell; Brian C Jensen; Leigh Ann Samsa; Daniel Marchuk; Wei Huang; Cecile Skrzynia; Christian Tilley; Bryce A Seifert; Edgar A Rivera-Muñoz; Beverly Koller; Kirk C Wilhelmsen; Jiandong Liu; Hassan Alhosaini; Karen E Weck; James P Evans; Jonathan S Berg
Journal:  Circ Cardiovasc Genet       Date:  2017-06

Review 2.  Neuromuscular diseases with hypertrophic cardiomyopathy.

Authors:  Sergi Cesar
Journal:  Glob Cardiol Sci Pract       Date:  2018-08-12

3.  Emerin Is Required for Proper Nucleus Reassembly after Mitosis: Implications for New Pathogenetic Mechanisms for Laminopathies Detected in EDMD1 Patients.

Authors:  Magda Dubińska-Magiera; Katarzyna Kozioł; Magdalena Machowska; Katarzyna Piekarowicz; Daria Filipczak; Ryszard Rzepecki
Journal:  Cells       Date:  2019-03-13       Impact factor: 6.600

4.  Targeted next-generation sequencing identified a known EMD mutation in a Chinese patient with Emery-Dreifuss muscular dystrophy.

Authors:  Xiafei Dai; Chenqing Zheng; Xuepin Chen; Yibin Tang; Hongmei Zhang; Chao Yan; Huihui Ma; Xiaoping Li
Journal:  Hum Genome Var       Date:  2019-09-03

5.  Autosomal dominant Emery-Dreifuss muscular dystrophy caused by a mutation in the lamin A/C gene identified by exome sequencing: a case report.

Authors:  Kristy Iskandar; Farida Niken Astari; Rizki Amalia Gumilang; Nissya Ilma; Ni Putu Shartyanie; Guritno Adistyawan; Grace Tan; Poh San Lai
Journal:  BMC Pediatr       Date:  2022-10-17       Impact factor: 2.567

6.  Transcriptional abnormalities of hamstring muscle contractures in children with cerebral palsy.

Authors:  Lucas R Smith; Henry G Chambers; Shankar Subramaniam; Richard L Lieber
Journal:  PLoS One       Date:  2012-08-16       Impact factor: 3.240

7.  Novel pathogenic variants and genes for myopathies identified by whole exome sequencing.

Authors:  Jesse M Hunter; Mary Ellen Ahearn; Christopher D Balak; Winnie S Liang; Ahmet Kurdoglu; Jason J Corneveaux; Megan Russell; Matthew J Huentelman; David W Craig; John Carpten; Stephen W Coons; Daphne E DeMello; Judith G Hall; Saunder M Bernes; Lisa Baumbach-Reardon
Journal:  Mol Genet Genomic Med       Date:  2015-04-08       Impact factor: 2.183

Review 8.  The nuclear envelope LEM-domain protein emerin.

Authors:  Jason M Berk; Kathryn E Tifft; Katherine L Wilson
Journal:  Nucleus       Date:  2013-07-17       Impact factor: 4.197

Review 9.  Clinical aspects of Emery-Dreifuss muscular dystrophy.

Authors:  Agnieszka Madej-Pilarczyk
Journal:  Nucleus       Date:  2018-01-01       Impact factor: 4.197

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.